Aldeyra The (ALDX)

Currency in USD
1.550
-0.050(-3.13%)
Closed·
1.531-0.019(-1.23%)
·
Earnings results expected in 5 days
ALDX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.5101.590
52 wk Range
1.0706.175
Key Statistics
Prev. Close
1.6
Open
1.58
Day's Range
1.51-1.59
52 wk Range
1.07-6.175
Volume
1.48M
Average Volume (3m)
3M
1-Year Change
-39.6226%
Book Value / Share
0.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALDX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.500
Upside
+383.87%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Aldeyra The News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, including ADX 248, ADX 246, and other novel RASP modulators for the treatment of various diseases associated with RASP. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Compare ALDX to Peers and Sector

Metrics to compare
ALDX
Peers
Sector
Relationship
P/E Ratio
−2.8x−5.0x−0.5x
PEG Ratio
−0.070.310.00
Price/Book
2.1x6.8x2.6x
Price / LTM Sales
-10.1x3.2x
Upside (Analyst Target)
-169.9%47.4%
Fair Value Upside
Unlock−17.2%7.7%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 7.500
(+383.87% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Hold2.00+29.03%10.00DowngradeMar 18, 2026
BTIG
Buy9.00+480.65%-MaintainMar 17, 2026
Jefferies
Buy7.00+351.61%6.00MaintainOct 08, 2025
Jones Trading
Buy9.00+480.65%6.00MaintainAug 08, 2025
Jones Trading
Buy6.00+287.10%-MaintainJun 26, 2025

Earnings

Latest Release
Feb 26, 2026
EPS / Forecast
-0.11 / -0.16
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ALDX Income Statement

People Also Watch

3.74
BATL
-7.43%
3.52
RCKT
-4.35%
2.42
REPL
-15.09%
3.2100
WNW
-12.05%

FAQ

What Is the Aldeyra The (ALDX) Stock Price Today?

The Aldeyra The stock price today is 1.550 USD.

What Stock Exchange Does Aldeyra The Trade On?

Aldeyra The is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Aldeyra The?

The stock symbol for Aldeyra The is "ALDX."

What Is the Aldeyra The Market Cap?

As of today, Aldeyra The market cap is 93.280M USD.

What Is Aldeyra The's Earnings Per Share (TTM)?

The Aldeyra The EPS (TTM) is -0.564.

When Is the Next Aldeyra The Earnings Date?

Aldeyra The will release its next earnings report on Apr 30, 2026.

From a Technical Analysis Perspective, Is ALDX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Aldeyra The Stock Split?

Aldeyra The has split 0 times.

How Many Employees Does Aldeyra The Have?

Aldeyra The has 8 employees.

What is the current trading status of Aldeyra The (ALDX)?

As of Apr 25, 2026, Aldeyra The (ALDX) is trading at a price of 1.550 USD, with a previous close of 1.600 USD. The stock has fluctuated within a day range of 1.510 USD to 1.590 USD, while its 52-week range spans from 1.070 USD to 6.175 USD.

What Is Aldeyra The (ALDX) Price Target According to Analysts?

The average 12-month price target for Aldeyra The is 7.500 USD, with a high estimate of 13 USD and a low estimate of 2 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +383.87% Upside potential.

What Is the ALDX Premarket Price?

ALDX's last pre-market stock price is 1.620 USD. The pre-market share volume is 13,170.000, and the stock has decreased by 0.020, or 1.250%.

What Is the ALDX After Hours Price?

ALDX's last after hours stock price is 1.531 USD, the stock has decreased by -0.019, or -1.230%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.